Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct 8:62:7.15.1-7.15.30.
doi: 10.1002/0471141755.ph0715s62.

Overview of experimental models of the blood-brain barrier in CNS drug discovery

Alan M Palmer  1 , Mohammad S Alavijeh  2
Affiliations
Review

Overview of experimental models of the blood-brain barrier in CNS drug discovery

Alan M Palmer et al. Curr Protoc Pharmacol. .

Abstract

The blood-brain barrier (BBB) is a physical and metabolic entity that isolates the brain from the systemic circulation. The barrier consists of tight junctions between endothelial cells that contain egress transporters and catabolic enzymes. To cross the BBB, a drug must possess the appropriate physicochemical properties to achieve a sufficient time-concentration profile in brain interstitial fluid (ISF). In this overview, we review techniques to measure BBB permeation, which is evidenced by the free concentration of compound in brain ISF over time. We consider a number of measurement techniques, including in vivo microdialysis and brain receptor occupancy following perfusion. Consideration is also given to the endothelial and nonendothelial cell systems used to assess both the BBB permeation of a test compound and its interactions with egress transporters, and computer models employed for predicting passive permeation and the probability of interactions with BBB transporters.

Keywords: MDCK cells; blood-brain barrier; brain disorders; brain medicines; drug discovery; in vivo microdialysis; neuroscience; receptor occupancy.

PubMed Disclaimer

References

Literature Cited

    1. Abbott, N.J. 2004. Evidence for bulk flow of brain interstitial fluid: Significance for physiology and pathology. Neurochem. Int. 45:545-552.
    1. Abbott, N.J. 2005. Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25:5-23.
    1. Abbott, N.J., Khan, E.U., Rollinson, C.M., Reichel, A., Janigro, D., Dombrowski, S.M., Dobbie, M.S., and Begley, D.J. 2002. Drug resistance in epilepsy: The role of the blood-brain barrier. Novartis Foundation Symposium. 243:38-47; discussion 47-53, 180-185.
    1. Abbott, N.J., Rönnbäck, L., and Hansson, E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41-53.
    1. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., and Begley, D.J. 2010. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37:13-25.

MeSH terms

Substances

LinkOut - more resources